Treating Bone Loss Ups Survival for Patients With Breast Cancer
Long-term data from a trial of adjuvant denosumab in patients with breast cancer suggest a survival benefit in addition to reduced fractures and increased bone density. Medscape Medical News
Long-term data from a trial of adjuvant denosumab in patients with breast cancer suggest a survival benefit in addition to reduced fractures and increased bone density. Medscape Medical News